
    
      The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial and The American
      Cancer Society Cancer Prevention Study II (CPS-II) investigators have identified 140 UADSCC
      cases that have been frequency matched 3:1 (420 controls) by incidence density sampling for
      study (ACS. PLCO), gender, ethnic background, and age, within 10 years.
    
  